Harper Ellsworth Advertising, in collaboration with their client Texas Radiotherapy, has been named a finalist for the 2024 MM+M Awards in the category of 'Use of Hospital or Healthcare Services Marketing.' The MM+M Awards are renowned for recognizing excellence in healthcare marketing and communications, making this nomination a significant achievement for the Dallas-based agency.
The MM+M Awards celebrate creativity and effectiveness within the healthcare marketing industry. Finalists are selected through a rigorous judging process involving more than 90 experts from various fields, ensuring that only the most outstanding entries make the cut. The awards gala is set to take place in New York City on October 10, 2024.
According to MM+M's Larry Dobrow, the volume and quality of work produced by the medical marketing community are impressive. 'It's an honor to celebrate the marketing that helps so many people achieve better health outcomes,' Dobrow stated, emphasizing the importance of such recognition within the industry.
Harper Ellsworth's CEO, Kathlene Simmons, expressed her excitement over the nomination. 'We are thrilled that our work for Texas Radiotherapy is selected as a finalist for such a prestigious award. This recognition is the result of incredible teamwork from many talented individuals. We all worked seamlessly together to help deliver the client's goals and make men more aware of prostate cancer,' Simmons said.
Project Creative Director Melvin Strobbe credited the success to the strong collaboration with Texas Radiotherapy. 'The key to our creative output was having such a great client: Texas Radiotherapy. Dr. Matthew and Sara Cavey were excellent on and off camera and helped us hone a strategy, profiling actual patients, that was based on patient truth,' Strobbe explained.
The recognition from the MM+M Awards highlights the impact of effective healthcare marketing strategies in promoting better health outcomes. By profiling real patients and focusing on genuine patient experiences, Harper Ellsworth and Texas Radiotherapy have successfully raised awareness about prostate cancer, potentially influencing public health positively.
For more information about the 2024 MM+M Awards, visit https://www.mmm-awards.com.
